Lyrica
Lyrica is the brand name for pregabalin, a prescription medication developed by Pfizer. It is an anticonvulsant and analgesic that does not act directly on GABA receptors. Instead, pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of several excitatory neurotransmitters and dampening neuronal excitability.
Approved indications include neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia, fibromyalgia, and as
Common side effects include dizziness, somnolence, dry mouth, edema, weight gain, blurred vision, and concentration difficulties.
Pregnancy and lactation: in the United States, pregabalin is a pregnancy category C drug; it should be